Amphastar Grows With Primatene Mist, Epinephrine And Glucagon

As Company Plans Vasopressin Launch in Q3 FY22

 
• By Akriti Seth
  
ladder
Amphastar grows by 26% in Q4 FY21 • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products